Trends in Biotechnology: Acquisitions, regulations and "Pink Biotech"
Results from the panel discussions at BIO-Europe 2006
17-Nov-2006 -
One of the most important questions, discussed on the BIO-Europe 2006, was, if major acquisitions is an indicative trend. The number of significant pharma acquisitions of biotech companies, over the year, is pointing to a new relationship between pharma and biotech businesses. Joshua Boger, ...
Amgen
AstraZeneca
biotechnology
+4